Aarti Pharmalabs Limited (AARTIPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 53.67B |
| Enterprise Value | 61.12B |
| P/E Ratio | 32.62 |
| PEG Ratio | 3.8 |
| Price/Sales Ratio | 3.87 |
| Price/Book Ratio | 3.71 |
| Enterprise/Revenue | 4.21 |
| Enterprise/EBITDA | 18.98 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 18.19B |
| Revenue/Share | 238.33 |
| Gross Profit | 9.85B |
| EBITDA | 3.84B |
| Net Income | 1.75B |
| Diluted EPS | 19.25 |
Balance Sheet
| Total Cash | 232.91M |
| Total Cash/Share | 2.57 |
| Total Debt | 7.37B |
| Total Debt/Equity | 0.33 |
| Current Ratio | 1.4 |
| Book Value Per Share | 248.65 |
Price History
| 52-Week Change | 19.69 |
| 52-Week High | 1,002.4 |
| 52-Week Low | 585 |
| Moving Average 50 Days | 883.49 |
| Moving Average 200 Days | 752.1 |
Statistics
| Average Volume | 697,766 |
| Shares Outstanding | 90.68M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.5 |
| Trailing Annual Dividend Yield | 0.38 |
| Payout Ratio | 0.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
